Similar Search Results

Keeping the Doctor Away : Experimental Evidence on Investment in Preventative Health Products

Meredith, Jennifer - 2013

curves for health products in Kenya, Guatemala, India, and Uganda and test whether (1) information about health risk, (2 …

Persistent link: https://www.econbiz.de/10013077947

Black Box Warnings and Drug Safety : Examining the Determinants and Timing of Fda Warning Labels

Begosh, Allan - 2013

Comparing the safety of prescription drugs over time is difficult due to the paucity of reliable quantitative measures of drug safety. Both the academic literature and popular press have focused on drug withdrawals as a proxy for breakdowns in the drug safety system. This metric, however, is...

Persistent link: https://www.econbiz.de/10012754051

The Effect of Deceptive Advertising on Consumption of the Advertised Good and its Substitutes : the Case of Over-the-Counter Weight Loss Products

Cawley, John H. - 2013

This paper is the first to estimate the impact of exposure to deceptive advertising on consumption of the advertised product and its substitutes. We study the market for over-the-counter (OTC) weight-loss products, a market in which deceptive advertising is rampant and products are generally...

Persistent link: https://www.econbiz.de/10013085499

When is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity

Kremer, Michael - 2013

We argue that in pharmaceutical markets, variation in the arrival time of consumer heterogeneity creates differences between a producer's ability to extract consumer surplus with preventives and treatments, potentially distorting R&D decisions. If consumers vary only in disease risk, revenue...

Persistent link: https://www.econbiz.de/10013085502

Patient Responses to Incentives in Consumer-Directed Health Plans : Evidence from Pharmaceuticals

Huckfeldt, Peter J. - 2015

use of pharmaceuticals for chronic diseases. We compare two large firms where nearly all employees were switched to CDHPs … to firms with conventional health insurance plans. In the first firm's CDHP, pharmaceuticals were subject to the … deductible, while in the second firm pharmaceuticals were exempt. Employees in the first firm shifted the timing of drug …

Persistent link: https://www.econbiz.de/10013028554

Towards an Efficient Mechanism for Prescription Drug Procurement

Fong, Kyna - 2010

This paper applies ideas from mechanism design to model procurement of prescription drugs. We present a mechanism for government-funded market-driven drug procurement that achieves very close to full static efficiency -- all members have access to all but at most a single drug -- without...

Persistent link: https://www.econbiz.de/10012757880

Take-Up of Medicare Part D : Results from the Health and Retirement Study

Levy, Helen - 2010

We analyze data from the Health and Retirement Study on senior citizens' take-up of Medicare Part D. Take-up among those without drug coverage in 2004 was high; about fifty to sixty percent of this group have Part D coverage in 2006. Only seven percent of senior citizens lack drug coverage in...

Persistent link: https://www.econbiz.de/10012757923

Demanding Customers : Consumerist Patients and Quality of Care

Fang, Hai - 2010

Consumerism arises when patients acquire and use medical information from sources apart from their physicians, such as the Internet and direct-to-patient advertising. Consumerism has been hailed as a means of improving quality. This need not be the result. Consumerist patients place additional...

Persistent link: https://www.econbiz.de/10012758353

Integrated Insurance Design in the Presence of Multiple Medical Technologies

Goldman, Dana P. - 2010

The classic theory of moral hazard concerns the insurance of a single good and predicts that co-insurance is larger when the elasticity of demand is higher and when small risks are insured. We extend this analysis to the insurance of multiple goods; for example, the simultaneous insurance of...

Persistent link: https://www.econbiz.de/10012760414

The Impact of Medicare Part D on Pharmaceutical R&D

Blume-Kohout, Margaret - 2009

Recent evidence suggests that Medicare Part D has increased prescription drug use among the elderly, and earlier studies have indicated that increasing market size induces pharmaceutical innovation. This paper assesses the impact of Medicare Part D on pharmaceutical research and development...

Persistent link: https://www.econbiz.de/10012766548